Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.92)
# 3,199
Out of 5,006 analysts
207
Total ratings
25.94%
Success rate
-2.66%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.08 | +733.33% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.57 | +1,291.55% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.47 | +247.35% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.36 | +69.49% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $3.57 | -43.98% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.48 | +1,559.06% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $3.35 | +467.16% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.88 | +629.17% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $2.48 | +504.84% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $56 | $0.77 | +7,140.76% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.69 | +1,342.79% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.57 | +253.98% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.49 | +568.15% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $9.08 | +109.25% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.86 | +459.44% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.18 | +408.47% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.33 | +7,418.80% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.62 | +2,810.74% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.19 | +813.24% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $6.21 | +253,523.19% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $21.00 | +2,280.95% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $22.50 | +966.67% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $2.32 | +3,348.28% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,500 | $14.30 | +10,389.51% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $7.66 | +104,338.64% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.28 | +446.88% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.50 | +1,100.00% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $3.16 | +1,165.82% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $10.10 | +78.22% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.44 | +12.61% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $4.68 | +30,669.23% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $60.64 | -60.42% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.61 | +212,322.36% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.99 | +954,673.87% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.08
Upside: +733.33%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.57
Upside: +1,291.55%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.47
Upside: +247.35%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.36
Upside: +69.49%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $3.57
Upside: -43.98%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.48
Upside: +1,559.06%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $3.35
Upside: +467.16%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.88
Upside: +629.17%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $2.48
Upside: +504.84%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $56
Current: $0.77
Upside: +7,140.76%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $0.69
Upside: +1,342.79%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.57
Upside: +253.98%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $4.49
Upside: +568.15%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $9.08
Upside: +109.25%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.86
Upside: +459.44%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.18
Upside: +408.47%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.33
Upside: +7,418.80%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $0.62
Upside: +2,810.74%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.19
Upside: +813.24%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $6.21
Upside: +253,523.19%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $21.00
Upside: +2,280.95%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $22.50
Upside: +966.67%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $2.32
Upside: +3,348.28%
Jun 30, 2021
Initiates: Buy
Price Target: $1,500
Current: $14.30
Upside: +10,389.51%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $7.66
Upside: +104,338.64%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.28
Upside: +446.88%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.50
Upside: +1,100.00%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $3.16
Upside: +1,165.82%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $10.10
Upside: +78.22%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $4.44
Upside: +12.61%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $4.68
Upside: +30,669.23%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $60.64
Upside: -60.42%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.61
Upside: +212,322.36%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.99
Upside: +954,673.87%